Literature DB >> 971346

Ischaemic disease in men and women with familial hypercholesterolaemia and xanthomatosis. A comparative study of genetic and environmental factors in 274 heterozygous cases.

V Beaumont, B Jacotot, J L Beaumont.   

Abstract

The incidence of ischaemic diseases in familial hypercholesterolaemia and xanthomatosis (familial Type II) was studied in a group of 158 men and 116 women. (1) Men and women did not differ with regard to the inherited metabolic disease. Levels of serum cholesterol, the marker of the genetic defect, were not statistically different, and cholesterol deposition in tissues, visualized by skin tendon xanthomas, was not sex related. (2) Men and women were different with regard to ischaemic diseases. The incidence was much lower in women, and the mean age of onset 9 years later. Moreover, there was a sex difference in the nature of the ischaemic disease, with a high male predominance of myocardial infarction. (3) Since the major risk factor hypercholesterolaemia could not explain such a difference, the role of other risk factors was investigated. It was shown that the incidence of ischaemic diseases was increased in women by cigarette smoking and hypertension, and that the difference in age of onset between males and females was no longer seen in smoking women. It is suggested that the genetic factor is responsible for the atherosclerotic lesion in both sexes and that other factors playing a role in ischaemic complications including tobacco and hypertension may explain the difference between men and women.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 971346     DOI: 10.1016/0021-9150(76)90136-2

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  15 in total

1.  Beyond the cholesterol profile: monitoring therapeutic effectiveness of statin therapy.

Authors:  R G Schwartz
Journal:  J Nucl Cardiol       Date:  2001 Jul-Aug       Impact factor: 5.952

Review 2.  Role of lipid-lowering pharmacotherapy in children.

Authors:  S Tonstad
Journal:  Paediatr Drugs       Date:  2000 Jan-Feb       Impact factor: 3.022

Review 3.  ABC of transfusion. Plasma, plasma products, and indications for their use.

Authors:  H Cohen; P B Kernoff
Journal:  BMJ       Date:  1990-03-24

4.  Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality study.

Authors:  E J Sijbrands; R G Westendorp; J C Defesche; P H de Meier; A H Smelt; J J Kastelein
Journal:  BMJ       Date:  2001-04-28

Review 5.  Identifying modifier genes of monogenic disease: strategies and difficulties.

Authors:  Emmanuelle Génin; Josué Feingold; Françoise Clerget-Darpoux
Journal:  Hum Genet       Date:  2008-09-11       Impact factor: 4.132

6.  Lipoprotein Particle Profiles, Standard Lipids, and Peripheral Artery Disease Incidence.

Authors:  Aaron W Aday; Patrick R Lawler; Nancy R Cook; Paul M Ridker; Samia Mora; Aruna D Pradhan
Journal:  Circulation       Date:  2018-11-20       Impact factor: 29.690

7.  Coronary artery disease and haemostatic variables in heterozygous familial hypercholesterolaemia.

Authors:  D D Sugrue; I Trayner; G R Thompson; V J Vere; J Dimeson; Y Stirling; T W Meade
Journal:  Br Heart J       Date:  1985-03

8.  Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group.

Authors: 
Journal:  BMJ       Date:  1991-10-12

Review 9.  Receptor-mediated low-density lipoprotein catabolism.

Authors:  F A Spengel; G R Thompson
Journal:  Klin Wochenschr       Date:  1982-04-01

10.  Contrasting patterns of coronary atherosclerosis in normocholesterolaemic smokers and patients with familial hypercholesterolaemia.

Authors:  D D Sugrue; G R Thompson; C M Oakley; I M Trayner; R E Steiner
Journal:  Br Med J (Clin Res Ed)       Date:  1981-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.